Compare Fox Corp Class A (FOXA) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Hinge Health Inc. Class A Common Stock — how do they compare? Fox Corp Class A trades at $62.63 (market cap $24.93B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Fox Corp Class A is far larger — about 2.9× Hinge Health Inc. Class A Common Stock's market cap, and Fox Corp Class A pays a 0.93% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class A for 35 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FOXA | HNGE | |
|---|---|---|
Market Cap | $24.93B | $8.48B |
Volume | 2,221,953 | 879,799 |
Sector | Media | Health |
52-Week High | $76.11 | $105.14 |
52-Week Low | $48.79 | $31.17 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $28.30B | $8.10B |
Dividend Yield | 0.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fox Corporation (FOXA) trades at $62.50, down slightly by 0.14% with a bearish technical signal. The company shows strong fundamentals with revenue growth from $14.0B in 2024 to $16.3B in 2025 and consistent earnings beats. Analyst consensus is bullish with a $72.00 price target, though the pending $22B Roku acquisition faces DOJ scrutiny. Cash flow improved significantly to $1.03B net in 2025, while 2026 projections show potential pressure.
FOXA presents a compelling value opportunity with reasonable valuations (P/E 16.3) and strong profitability (ROE 14.29%). The Roku deal represents both growth potential and regulatory risk. With zero sell ratings and insider buying, institutional sentiment remains positive despite technical weakness. Key risks include integration challenges and advertising market volatility.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
